title: Paclitaxel plus gemcitabine may be as active and well tolerated as paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
authors.affiliation: Chest Department, School of Medicine, National Yang-Ming University, Taipei Veterans General Hospital, Taiwan. ymchen@vghtpe.gov.tw
authors.forename: Yuh-Min
authors.initials: YM
authors.lastname: Chen